|Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)||
||118||All||18 Years and older (Adult, Senior)||NCT00790400||CRAD001M2302
|EXIST-2||April 2009||June 2011||November 2015||November 13, 2008||February 17, 2017||August 28, 2012||
|2||NCT02325505||Recruiting||Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma||
||Other / Industry||
||200||All||Child, Adult, Senior||NCT02325505||4147/14/127||April 2016||April 2018||April 2018||December 25, 2014||August 22, 2017||
† Study has passed its completion date and status has not been verified in more than two years.